Koers Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0011042806
Holdingvennootschappen
Omzet 2022 | 370K 102K 37 mln. 93,4K | Omzet 2023 | 104K 28,67K 10,4 mln. 26,25K | Marktkapitalisatie | 62,27 mln. 17,17 mln. 6,23 mld. 15,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -61 mln. -16,82 mln. -6,1 mld. -15,4 mln. | Nettowinst (verlies) 2023 | -31 mln. -8,55 mln. -3,1 mld. -7,83 mln. | EV/omzet 2022 | 331 x |
Nettoschuld 2022 | 23,85 mln. 6,57 mln. 2,38 mld. 6,02 mln. | Nettoschuld 2023 | 22,4 mln. 6,18 mln. 2,24 mld. 5,65 mln. | EV/omzet 2023 | 814 x |
K/w-verhouding 2022 |
-1,6
x | K/w-verhouding 2023 |
-2,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,22% | 85,34 mld. | |
+14,60% | 18,22 mld. | |
+59,87% | 17,63 mld. | |
+7,02% | 14,28 mld. | |
+27,68% | 13,05 mld. | |
-2,32% | 12,51 mld. | |
+0,18% | 11,13 mld. | |
+37,90% | 10,83 mld. | |
+100,57% | 10,15 mld. |